| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |